13D/13G Filings - BCTG Holdings, LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-01-02
07:07 am
Sale
2024-12-30 13D Tango Therapeutics, Inc.
TNGX
BCTG Holdings, LLC 10,740,385
10.000%
-4,473,668decrease
(-29.40%)
Filing
History
2023-10-18
5:23 pm
Purchase
2023-10-16 13D Tango Therapeutics, Inc.
TNGX
BCTG Holdings, LLC 15,214,053
15.000%
1,075,000increase
(+7.60%)
Filing
History
2023-08-16
4:40 pm
Purchase
2023-08-11 13D Tango Therapeutics, Inc.
TNGX
BCTG Holdings, LLC 14,139,053
13.900%
7,150,603increase
(+102.32%)
Filing
History
2022-01-04
5:03 pm
Unchanged
2021-08-10 13D Tango Therapeutics, Inc.
TNGX
BCTG Holdings, LLC 6,988,450
8.000%
0
(Unchanged)
Filing
History
2021-08-20
4:31 pm
Purchase
2021-08-10 13D Tango Therapeutics, Inc.
TNGX
BCTG Holdings, LLC 6,988,450
8.300%
6,988,450increase
(New Position)
Filing
History
2021-02-16
4:35 pm
Purchase
2020-12-31 13G BCTG Acquisition Corp.
BCTG
BCTG Holdings, LLC 4,488,450
21.000%
4,488,450increase
(New Position)
Filing
History